E. Weiss

Bypassing hybridoma technology: HLA-C reactive human single-chain antibody fragments (scFv) derived from a synthetic phage display library (HuCAL) and their potential to discriminate HLA class I specificities.

M. Tesar, D. Kabelitz, M. Krönke, 2000, Tissue antigens.

Generation of antibody-based therapeutics targeting the Idiotype of B-cell Malignancies.

Mitchell Ho, R. Kreitman, A. Antignani, 2018, Antibody therapeutics.